{"id":888090,"date":"2025-09-19T17:59:57","date_gmt":"2025-09-19T21:59:57","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\/"},"modified":"2025-09-19T17:59:57","modified_gmt":"2025-09-19T21:59:57","slug":"investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\/","title":{"rendered":"Investors who lost money on Alto Neuroscience, Inc.(ANRO) should contact Levi &amp; Korsinsky about pending Class Action &#8211; ANRO"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, Sept.  19, 2025  (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in <strong>Alto Neuroscience, Inc.<\/strong> (&#8220;Alto Neuroscience, Inc.&#8221; or the &#8220;Company&#8221;) (NYSE: ANRO) of a class action securities lawsuit.<\/p>\n<p>\n        <strong>CLASS DEFINITION: <\/strong>The lawsuit seeks to recover losses on behalf of Alto Neuroscience, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of a class consisting of all persons and entities that purchased or otherwise acquired: (a) Alto common stock pursuant and\/or traceable to the Offering Documents issued in connection with the Company\u2019s initial public offering conducted on or about February 2, 2024; and\/or (b) Alto securities between February 2, 2024 and October 22, 2024, both dates inclusive. Follow the link below to get more information and be contacted by a member of our team:<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ye5aQZYuls_KYcSXqLBPRTAVZ3bSKuYqSLc9UsWKfyY3HPqlA6IAGYF-7C0gwn94h9jvaDDpCplH-nNJBLoH0M7UxtCPGOlm_Dbrm9JcaRc7ePWdG7UVz5RgfVUP2fi_DC73D3KtG3FsTsFwkc55oLs4XHfsXPGo0YXQspwKmrpexQvo-GtZGB7cNOg4zYm9M50oW0FBExfxNgVQKMybrCURm5L0ACF07rt8-d7VdD_j-tt734RwnJ69L5yukI0ldKxp_dACbPKkRys-eMg1mw==\" rel=\"nofollow\" target=\"_blank\">https:\/\/zlk.com\/pslra-1\/alto-neuroscience-inc-lawsuit-submission-form?prid=168132&amp;wire=3<\/a>\n      <\/p>\n<p>\n        <strong>ANRO<\/strong> investors may also contact Joseph E. Levi, Esq. via email at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nXik_tHpfloFq2g8adnOzSaOke8CuZTIJ29dWhV3VS7N_-WBYhmvy60TQ5Lp7K6utDlC9d3qgUAHxR1qMRB8TdEpcg4Vf2LIfGR9n4FdxJo=\" rel=\"nofollow\" target=\"_blank\">jlevi@levikorsinsky.co<\/a>m or by telephone at (212) 363-7500.<\/p>\n<p>\n        <strong>CASE DETAILS: <\/strong>The filed complaint alleges that defendants made false statements and\/or concealed that: (i) The Company\u2019s product pipeline, ALTO-100, was less effective in treating major depressive disorder than defendants had led investors to believe; (ii) accordingly, ALTO-100\u2019s clinical, regulatory, and commercial prospects were overstated; (iii) as a result, Alto\u2019s business and\/or financial prospects were overstated; and (iv) as a result, the Company\u2019s public statements were materially false and misleading at all relevant times.<\/p>\n<p>\n        <strong>WHAT&#8217;S NEXT? <\/strong>If you suffered a loss in Alto Neuroscience, Inc. during the relevant time frame, you have until <strong>September 19, 2025<\/strong>\u00a0to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn&#8217;t require that you serve as a lead plaintiff.<\/p>\n<p>\n        <strong>NO COST TO YOU: <\/strong>If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. <strong>There is no cost or obligation to participate.<\/strong><\/p>\n<p>\n        <strong>WHY LEVI &amp; KORSINSKY: <\/strong>Over the past 20 years, the team at Levi &amp; Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi &amp; Korsinsky has ranked in ISS Securities Class Action Services\u2019 Top 50 Report as one of the top securities litigation firms in the United States.<\/p>\n<p>\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>Levi &amp; Korsinsky, LLP <br \/>Joseph E. Levi, Esq.<br \/>Ed Korsinsky, Esq.<br \/>33 Whitehall Street, 17th Floor<br \/>New York, NY 10004<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nXik_tHpfloFq2g8adnOzSaOke8CuZTIJ29dWhV3VS47fdHc4Qxgn4D7HbVpt0OTLBWiXg-mGcUqQBmhZumCFDCIyOu-dnbG_VIlp_jzKTg=\" rel=\"nofollow\" target=\"_blank\">jlevi@levikorsinsky.com<\/a><br \/>Tel: (212) 363-7500<br \/>Fax: (212) 363-7171<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kH7MVzP5NYtRjmKWjYTQRdSFAMQjbOQ7pJsSkfjtg7Q-Sl97Lto-hrfe6zGo_CEcBEEjqPhgNdPEWe-GV92NkQ==\" rel=\"nofollow\" target=\"_blank\">www.zlk.com<\/a>\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzMTc4MSM3MTU0ODk5IzIwMjA0MjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OWQ2YzdmZWYtMTQwMi00OWUxLWI5YTEtNGI1ZWU4OGFhYTYyLTEwMzIyOTMtMjAyNS0wOS0xOS1lbg==\/tiny\/Levi-Korsinsky-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in Alto Neuroscience, Inc. (&#8220;Alto Neuroscience, Inc.&#8221; or the &#8220;Company&#8221;) (NYSE: ANRO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Alto Neuroscience, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of a class consisting of all persons and entities that purchased or otherwise acquired: (a) Alto common stock pursuant and\/or traceable to the Offering Documents issued in connection with the Company\u2019s initial public offering conducted on or about February 2, 2024; and\/or (b) Alto securities between February 2, 2024 and October 22, 2024, both dates inclusive. Follow the link below &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Investors who lost money on Alto Neuroscience, Inc.(ANRO) should contact Levi &amp; Korsinsky about pending Class Action &#8211; ANRO&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-888090","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Investors who lost money on Alto Neuroscience, Inc.(ANRO) should contact Levi &amp; Korsinsky about pending Class Action - ANRO - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Investors who lost money on Alto Neuroscience, Inc.(ANRO) should contact Levi &amp; Korsinsky about pending Class Action - ANRO - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in Alto Neuroscience, Inc. (&#8220;Alto Neuroscience, Inc.&#8221; or the &#8220;Company&#8221;) (NYSE: ANRO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Alto Neuroscience, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of a class consisting of all persons and entities that purchased or otherwise acquired: (a) Alto common stock pursuant and\/or traceable to the Offering Documents issued in connection with the Company\u2019s initial public offering conducted on or about February 2, 2024; and\/or (b) Alto securities between February 2, 2024 and October 22, 2024, both dates inclusive. Follow the link below &hellip; Continue reading &quot;Investors who lost money on Alto Neuroscience, Inc.(ANRO) should contact Levi &amp; Korsinsky about pending Class Action &#8211; ANRO&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-19T21:59:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzMTc4MSM3MTU0ODk5IzIwMjA0MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Investors who lost money on Alto Neuroscience, Inc.(ANRO) should contact Levi &amp; Korsinsky about pending Class Action &#8211; ANRO\",\"datePublished\":\"2025-09-19T21:59:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\\\/\"},\"wordCount\":447,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzMTc4MSM3MTU0ODk5IzIwMjA0MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\\\/\",\"name\":\"Investors who lost money on Alto Neuroscience, Inc.(ANRO) should contact Levi &amp; Korsinsky about pending Class Action - ANRO - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzMTc4MSM3MTU0ODk5IzIwMjA0MjY=\",\"datePublished\":\"2025-09-19T21:59:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzMTc4MSM3MTU0ODk5IzIwMjA0MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzMTc4MSM3MTU0ODk5IzIwMjA0MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investors who lost money on Alto Neuroscience, Inc.(ANRO) should contact Levi &amp; Korsinsky about pending Class Action &#8211; ANRO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Investors who lost money on Alto Neuroscience, Inc.(ANRO) should contact Levi &amp; Korsinsky about pending Class Action - ANRO - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\/","og_locale":"en_US","og_type":"article","og_title":"Investors who lost money on Alto Neuroscience, Inc.(ANRO) should contact Levi &amp; Korsinsky about pending Class Action - ANRO - Market Newsdesk","og_description":"NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in Alto Neuroscience, Inc. (&#8220;Alto Neuroscience, Inc.&#8221; or the &#8220;Company&#8221;) (NYSE: ANRO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Alto Neuroscience, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of a class consisting of all persons and entities that purchased or otherwise acquired: (a) Alto common stock pursuant and\/or traceable to the Offering Documents issued in connection with the Company\u2019s initial public offering conducted on or about February 2, 2024; and\/or (b) Alto securities between February 2, 2024 and October 22, 2024, both dates inclusive. Follow the link below &hellip; Continue reading \"Investors who lost money on Alto Neuroscience, Inc.(ANRO) should contact Levi &amp; Korsinsky about pending Class Action &#8211; ANRO\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\/","og_site_name":"Market Newsdesk","article_published_time":"2025-09-19T21:59:57+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzMTc4MSM3MTU0ODk5IzIwMjA0MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Investors who lost money on Alto Neuroscience, Inc.(ANRO) should contact Levi &amp; Korsinsky about pending Class Action &#8211; ANRO","datePublished":"2025-09-19T21:59:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\/"},"wordCount":447,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzMTc4MSM3MTU0ODk5IzIwMjA0MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\/","name":"Investors who lost money on Alto Neuroscience, Inc.(ANRO) should contact Levi &amp; Korsinsky about pending Class Action - ANRO - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzMTc4MSM3MTU0ODk5IzIwMjA0MjY=","datePublished":"2025-09-19T21:59:57+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzMTc4MSM3MTU0ODk5IzIwMjA0MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzMTc4MSM3MTU0ODk5IzIwMjA0MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-who-lost-money-on-alto-neuroscience-inc-anro-should-contact-levi-korsinsky-about-pending-class-action-anro-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Investors who lost money on Alto Neuroscience, Inc.(ANRO) should contact Levi &amp; Korsinsky about pending Class Action &#8211; ANRO"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/888090","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=888090"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/888090\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=888090"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=888090"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=888090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}